These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23602653)

  • 21. New therapies for chronic obstructive pulmonary disease.
    Krishna G; Sankaranarayanan V; Chitkara RK
    Expert Opin Investig Drugs; 2004 Mar; 13(3):255-67. PubMed ID: 15013944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of chronic obstructive pulmonary disease--traditional bronchodilatation and targeted anti-inflammatory therapy].
    Mróz RM; Skopiński T; Hołownia A; Chyczewska E; Braszko JJ
    Pneumonol Alergol Pol; 2011; 79(1):32-8. PubMed ID: 21190151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging drugs for chronic obstructive pulmonary disease.
    Matera MG; Calzetta L; Segreti A; Cazzola M
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):61-82. PubMed ID: 22335427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Novartis view on emerging drugs and novel targets for the treatment of chronic obstructive pulmonary disease.
    Compton C; McBryan D; Bucchioni E; Patalano F
    Pulm Pharmacol Ther; 2013 Oct; 26(5):562-73. PubMed ID: 23748050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic obstructive pulmonary disease: new opportunities for drug development.
    Barnes PJ
    Trends Pharmacol Sci; 1998 Oct; 19(10):415-23. PubMed ID: 9803832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New treatments for chronic obstructive pulmonary disease.
    Barnes PJ
    Ann Ist Super Sanita; 2003; 39(4):573-82. PubMed ID: 15098577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease.
    Lipworth BJ
    Lancet; 2005 Jan 8-14; 365(9454):167-75. PubMed ID: 15639300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.
    Hatzelmann A; Morcillo EJ; Lungarella G; Adnot S; Sanjar S; Beume R; Schudt C; Tenor H
    Pulm Pharmacol Ther; 2010 Aug; 23(4):235-56. PubMed ID: 20381629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Future treatment strategies for COPD.
    Friedman M
    Clin Cornerstone; 2003; 5(1):45-51. PubMed ID: 12739311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA
    Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Future Advances in COPD Therapy.
    Barnes PJ
    Respiration; 2001; 68(5):441-8. PubMed ID: 11694802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New drug therapies for COPD.
    Ross CL; Hansel TT
    Clin Chest Med; 2014 Mar; 35(1):219-39. PubMed ID: 24507848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospects for COPD treatment.
    Matera MG; Cazzola M; Page C
    Curr Opin Pharmacol; 2021 Feb; 56():74-84. PubMed ID: 33333428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bronchodilators in chronic obstructive pulmonary disease (COPD)].
    Gillissen A; Buhl R; Rabe KF; Vogelmeier C; Welte T
    Med Klin (Munich); 2005 May; 100(5):246-54. PubMed ID: 15902378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphodiesterase inhibitors for the treatment of asthma and chronic obstructive pulmonary disease.
    Page CP
    Int Arch Allergy Immunol; 2014; 165(3):152-64. PubMed ID: 25532037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
    Onoue S; Misaka S; Kawabata Y; Yamada S
    Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease?
    Reddy CB; Kanner RE
    Drugs Aging; 2007; 24(8):615-28. PubMed ID: 17702532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic obstructive pulmonary disease--a treatable disease.
    Osthoff M; Jenkins C; Leuppi J
    Swiss Med Wkly; 2013; 143():w13777. PubMed ID: 23592218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacological treatment of COPD. Where are we now?].
    Calle Rubio M; Pinedo Sierra C; Rodríguez Hermosa JL
    Arch Bronconeumol; 2010 Dec; 46 Suppl 10():3-7. PubMed ID: 21316549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New anti-inflammatory targets for chronic obstructive pulmonary disease.
    Barnes PJ
    Nat Rev Drug Discov; 2013 Jul; 12(7):543-59. PubMed ID: 23977698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.